Annexon, Inc. (ANNX) was able to achieve positive results from its phase 3 study for the treatment of patients with Guillain-Barré syndrome [GBS]. Matter of fact, it noted that a lower dose of its ...
Hansa Biopharma, “Hansa”, today announced positive high-level data from the 15-HMedIdeS-09 phase 2 trial that demonstrated imlifidase was safe and well tolerated when administered prior to standard of ...
The FDA granted Pfizer a breakthrough therapy designation for its group B Streptococcus vaccine candidate for pregnant people to prevent GBS disease in newborns based on its ongoing phase 2 trial. GBS ...
Group B Streptococcus (also known as group B strep or GBS) is a common bacterium found in the rectum, digestive tract, and urinary tract of men and women. It’s also found in a woman’s vagina. GBS ...
(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today ...
Group B Streptococcus, which people may call group B strep (GBS), is a type of bacterium that causes GBS disease. GBS can lead to meningitis, which is an infection of the lining of the brain and ...
Researchers in Norway studied rates of fatalities and long-term neurodevelopmental disorders among 866 infants diagnosed with GBS infection. Children with GBS meningitis died at higher rates than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback